The Oncology Institute, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.36 M | $1.04 M | 0.00% | 4.45% |
| TIFF ADVISORY SERVICES INC | 02/06/2025 | 2.98 M | $920,555 | 13.15% | 3.94% |
| CINCINNATI INSURANCE CO | 02/12/2025 | 2.03 M | $628,520 | 0.00% | 2.69% |
| VANGUARD GROUP INC | 02/11/2025 | 1.75 M | $542,105 | -1.63% | 2.32% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 1.73 M | $533,199 | 0.00% | 2.28% |
| FREEGULLIVER LLC | 02/11/2025 | 600,747 | $185,631 | 219.26% | 0.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 347,347 | $107,360 | -8.59% | 0.46% |
| FOURWORLD CAPITAL MANAGEMENT LLC | 02/14/2025 | 257,000 | $79,413 | 0.00% | 0.34% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 253,591 | $78,360 | 0.26% | 0.34% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 182,000 | $56,238 | 7.06% | 0.24% |
| QUATTRO FINANCIAL ADVISORS LLC | 01/28/2025 | 162,724 | $112,686 | 0.00% | 0.22% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 131,759 | $41,000 | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 02/14/2025 | 127,659 | $39,447 | 613.58% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 125,141 | $38,668 | 0.00% | 0.17% |
| STATE STREET CORP | 02/14/2025 | 101,300 | $31,302 | 0.00% | 0.13% |
| SABA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 94,264 | $29,128 | 0.00% | 0.12% |
| LEE FINANCIAL CO | 01/30/2025 | 81,362 | $25,141 | 0.00% | 0.11% |
| HIGHTOWER ADVISORS, LLC | 02/07/2025 | 81,362 | $25,141 | 0.00% | 0.11% |
| FIELDER CAPITAL GROUP LLC | 02/05/2025 | 70,192 | $21,689 | 0.00% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 61,961 | $19,146 | 100.00% | 0.08% |
| XTX TOPCO LTD | 02/13/2025 | 37,250 | $11,510 | 48.35% | 0.05% |
| SCIENTECH RESEARCH LLC | 02/14/2025 | 21,198 | $6,550 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 13,540 | $4,184 | 53.88% | 0.02% |
| AMG NATIONAL TRUST BANK | 02/07/2025 | 10,000 | $3,090 | 0.00% | 0.01% |
| CITIGROUP INC | 02/12/2025 | 634 | $196 | 2,436.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 166 | $51 | -2.92% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 5 | $2 | 100.00% | 0.00% |
| FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| BOSTON FINANCIAL MANGEMENT LLC | 02/03/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CRESSET ASSET MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
The Oncology Institute, Inc. institutional Ownership - FAQ's
During the previous two years, 42 institutional investors and hedge funds held shares of The Oncology Institute, Inc.. The most heavily invested institutionals were:
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.36 M
TIFF ADVISORY SERVICES INC: 2.98 M
CINCINNATI INSURANCE CO: 2.03 M
VANGUARD GROUP INC: 1.75 M
BALYASNY ASSET MANAGEMENT L.P.: 1.73 M
FreeGulliver LLC: 600,747
19.48% of The Oncology Institute, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.82 M shares in the last 24 months. This purchase volume represents approximately $5.70 M in transactions.